BR112021024848A2 - Métodos de purificação de anticorpos e composições dos mesmos - Google Patents

Métodos de purificação de anticorpos e composições dos mesmos

Info

Publication number
BR112021024848A2
BR112021024848A2 BR112021024848A BR112021024848A BR112021024848A2 BR 112021024848 A2 BR112021024848 A2 BR 112021024848A2 BR 112021024848 A BR112021024848 A BR 112021024848A BR 112021024848 A BR112021024848 A BR 112021024848A BR 112021024848 A2 BR112021024848 A2 BR 112021024848A2
Authority
BR
Brazil
Prior art keywords
compositions
purification methods
antibody purification
antibody
methods
Prior art date
Application number
BR112021024848A
Other languages
English (en)
Inventor
George Parks
Lutfiye Kurt
E Dolan Michael
Norbert Schuelke
F Oppenheim Sheldon
Original Assignee
Takeda Pharmaceuticals Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceuticals Co filed Critical Takeda Pharmaceuticals Co
Publication of BR112021024848A2 publication Critical patent/BR112021024848A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/165—Extraction; Separation; Purification by chromatography mixed-mode chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/005—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies constructed by phage libraries
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

métodos de purificação de anticorpos e composições dos mesmos. a presente invenção refere-se a métodos de purificação de um anticorpo ¿4¿7 humanizado, tal como vedolizumabe, produzido em uma cultura de células de mamífero são descritos neste documento, assim como são composições resultantes dos referidos processos de purificação.
BR112021024848A 2019-06-10 2020-06-10 Métodos de purificação de anticorpos e composições dos mesmos BR112021024848A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962859580P 2019-06-10 2019-06-10
PCT/US2020/037069 WO2020252072A1 (en) 2019-06-10 2020-06-10 Antibody purification methods and compositions thereof

Publications (1)

Publication Number Publication Date
BR112021024848A2 true BR112021024848A2 (pt) 2022-01-18

Family

ID=73782230

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112021024848A BR112021024848A2 (pt) 2019-06-10 2020-06-10 Métodos de purificação de anticorpos e composições dos mesmos

Country Status (14)

Country Link
US (1) US20220259291A1 (pt)
EP (1) EP3980119A4 (pt)
JP (1) JP2022536659A (pt)
CN (1) CN114025843A (pt)
AR (1) AR119268A1 (pt)
AU (1) AU2020290999A1 (pt)
BR (1) BR112021024848A2 (pt)
CA (1) CA3143169A1 (pt)
IL (1) IL288830A (pt)
MA (1) MA56132A (pt)
MX (1) MX2021015302A (pt)
PL (1) PL439807A1 (pt)
TW (1) TW202112800A (pt)
WO (1) WO2020252072A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019198099A1 (en) * 2018-04-10 2019-10-17 Dr. Reddy's Laboratories Limited Stable antibody formulation
WO2023012828A1 (en) * 2021-08-05 2023-02-09 Dr. Reddy's Laboratories Limited Method to purify an antibody composition using cation exchange chromatography
EP4396195A1 (en) * 2021-09-03 2024-07-10 Dr. Reddy's Laboratories Limited Method to obtain a purified antibody composition
WO2023180523A1 (en) * 2022-03-24 2023-09-28 Pieris Pharmaceuticals Gmbh Process for purifying fusion proteins

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2453558C2 (ru) * 2004-09-03 2012-06-20 Дженентек, Инк. Гуманизированные антагонистические антитела против бета7 и их применение
TWI723339B (zh) * 2011-05-02 2021-04-01 美商千禧製藥公司 抗-α4β7抗體之調配物
PL3116891T3 (pl) * 2014-03-10 2020-07-27 Richter Gedeon Nyrt. Oczyszczanie immunoglobuliny z zastosowaniem etapów wstępnego oczyszczania
WO2018104893A1 (en) * 2016-12-06 2018-06-14 Glaxosmithkline Intellectual Property Development Limited Alpha4-beta7 antibodies with incrased fcrn binding and/or half-life

Also Published As

Publication number Publication date
WO2020252072A1 (en) 2020-12-17
MA56132A (fr) 2022-04-13
JP2022536659A (ja) 2022-08-18
US20220259291A1 (en) 2022-08-18
IL288830A (en) 2022-02-01
AU2020290999A1 (en) 2022-02-03
TW202112800A (zh) 2021-04-01
CA3143169A1 (en) 2020-12-17
CN114025843A (zh) 2022-02-08
EP3980119A4 (en) 2023-06-07
MX2021015302A (es) 2022-01-18
PL439807A1 (pl) 2022-12-05
EP3980119A1 (en) 2022-04-13
AR119268A1 (es) 2021-12-09

Similar Documents

Publication Publication Date Title
BR112021024848A2 (pt) Métodos de purificação de anticorpos e composições dos mesmos
BR112018075516A2 (pt) purificação de anticorpos multiespecíficos
EA201891532A1 (ru) Композиции и способы лечения гемоглобинопатий
ZA201804654B (en) Anti-cd74 antibody conjugates, compositions comprising anti-cd74 antibody conjugates and methods of using anti-cd74 antibody conjugates
TR201901445T4 (tr) Il2rbeta/yaygın gamma zinciri antikorları.
EA201992670A1 (ru) Способ получения биспецифических антител, биспецифические антитела и терапевтическое применение таких антител
EA201691581A1 (ru) Способы и композиции для повышения эффективности направленной модификации генов с применением опосредованной олигонуклеотидами репарации генов
AR114283A1 (es) Receptores quiméricos de dll3 y métodos para su uso
BR112017003582A2 (pt) anticorpos, composições e usos
BR112021023345A2 (pt) Imunotolerância com alvo em madcam
EA201491571A1 (ru) МОДИФИЦИРОВАННЫЕ БИСПЕЦИФИЧЕСКИЕ АНТИТЕЛА IgG4 С АСИММЕТРИЧНОЙ ПОСЛЕДОВАТЕЛЬНОСТЬЮ
EP4036240A3 (en) Transduction buffer
EA201171018A1 (ru) Биореактор для культивирования клеток млекопитающих
EA201992232A1 (ru) Композиции и способы для иммуноонкологии
EA201490452A1 (ru) Ингибиторы тирозинкиназы брутона
MX2014007549A (es) 2-oxo-1,3-dioxolan-4-carboxamidas, su preparacion y uso.
BR112014015905A8 (pt) composição
GB2496337A (en) Combination pharmaceutical composition and methods of treating diseases or conditions associated with neurodegenerative diseases
EA201391389A1 (ru) Кристаллы антител против склеростина и составы на их основе
EA201390639A1 (ru) Производные 2-пиперазин-1-ил-4н-1,3-бензотиазин-4-она и их применение для лечения инфекций у млекопитающих
EA201892820A1 (ru) Способ стабилизации белков
TR201914501A2 (tr) Aeroponi̇k i̇ç ortam bi̇tki̇ yeti̇şti̇rme modülleri̇
EA201990998A1 (ru) Фармацевтические составы и способы их получения
AR119858A1 (es) Bacilos de temperatura optimizada
EA201990128A1 (ru) Культуры клеточных линий из растений, принадлежащих к роду harpagophytum

Legal Events

Date Code Title Description
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]